Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ferrocene-containing hybrids as potential anticancer agents: Current developments, mechanisms of action and structure-activity relationships
Ruo Wang, Huahong Chen, Weitao Yan, et al.
European Journal of Medicinal Chemistry (2020) Vol. 190, pp. 112109-112109
Closed Access | Times Cited: 164

Showing 1-25 of 164 citing articles:

Latest developments in metal complexes as anticancer agents
Renata Paprocka, Małgorzata Wiese-Szadkowska, Sabina Janciauskiene, et al.
Coordination Chemistry Reviews (2021) Vol. 452, pp. 214307-214307
Closed Access | Times Cited: 185
Ferroptosis‐Enhanced Cancer Immunity by a Ferrocene‐Appended Iridium(III) Diphosphine Complex
Wenjin Wang, Yu‐Yi Ling, Yanmei Zhong, et al.
Angewandte Chemie International Edition (2021) Vol. 61, Iss. 16
Closed Access | Times Cited: 132
A review on metal complexes and its anti-cancer activities: Recent updates from in vivo studies
Suman Adhikari, Priyatosh Nath, Alakesh Das, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116211-116211
Open Access | Times Cited: 64
Latest developments in coumarin-based anticancer agents: mechanism of action and structure–activity relationship studies
Manankar Koley, Jianlin Han, Vadim A. Soloshonok, et al.
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 10-54
Open Access | Times Cited: 43
Assessment of the electrostatic binding of ferrocenylmethyl-nitroaniline derivatives to DNA: A combined experimental and theoretical study
Touhami Lanez, Mehran Feizi‐Dehnayebi, Elhafnaoui Lanez
Journal of Molecular Structure (2024) Vol. 1308, pp. 138386-138386
Closed Access | Times Cited: 34
Pyrazoline Hybrids as Promising Anticancer Agents: An Up-to-Date Overview
Dimitris Matiadis, Marina Sagnou
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5507-5507
Open Access | Times Cited: 116
Diketopyrrolopyrrole‐derived organic small molecular dyes for tumor phototheranostics
Qianli Ma, Xu Sun, Weili Wang, et al.
Chinese Chemical Letters (2021) Vol. 33, Iss. 4, pp. 1681-1692
Closed Access | Times Cited: 94
Self‐Amplifying Iridium(III) Photosensitizer for Ferroptosis‐Mediated Immunotherapy Against Transferrin Receptor‐Overexpressing Cancer
Yu‐Yi Ling, Wen‐Jin Wang, Hao Liang, et al.
Small (2022) Vol. 18, Iss. 49
Closed Access | Times Cited: 43
Poly-L-lysine-modified with ferrocene to obtain a redox polymer for mediated glucose biosensor application
Dulce V. Estrada-Osorio, Ricardo A. Escalona-Villalpando, Arnaud Gutierrez, et al.
Bioelectrochemistry (2022) Vol. 146, pp. 108147-108147
Closed Access | Times Cited: 42
Salt-Tolerant Plants, Halophytes, as Renewable Natural Resources for Cancer Prevention and Treatment: Roles of Phenolics and Flavonoids in Immunomodulation and Suppression of Oxidative Stress towards Cancer Management
Hamdoon A. Mohammed, Abdul‐Hamid Emwas, Riaz A. Khan
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5171-5171
Open Access | Times Cited: 40
Ferrocene-Based Drugs, Delivery Nanomaterials and Fenton Mechanism: State of the Art, Recent Developments and Prospects
Cátia Ornelas, Didier Astruc
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2044-2044
Open Access | Times Cited: 40
How does ferrocene correlate with ferroptosis? Multiple approaches to explore ferrocene-appended GPX4 inhibitors as anticancer agents
Wei Li, Jing Yu, Jing Wang, et al.
Chemical Science (2024) Vol. 15, Iss. 27, pp. 10477-10490
Open Access | Times Cited: 12
Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010–2020)
Jiaqi Xiao, Meixiang Gao, Zhou Sun, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112830-112830
Closed Access | Times Cited: 61
Recent advances in iron-complexes as drug candidates for cancer therapy: reactivity, mechanism of action and metabolites
Mathilde Bouché, Cécilia Hognon, Stéphanie Grandemange, et al.
Dalton Transactions (2020) Vol. 49, Iss. 33, pp. 11451-11466
Open Access | Times Cited: 54
Exploring the Potential of Metallodrugs as Chemotherapeutics for Triple Negative Breast Cancer
Nazia Nayeem, Marı́a Contel
Chemistry - A European Journal (2021) Vol. 27, Iss. 35, pp. 8891-8917
Open Access | Times Cited: 49
Graphene quantum dot formulation for cancer imaging and redox-based drug delivery
Elizabeth A. Campbell, Md. Tanvir Hasan, Roberto González-Rodríguez, et al.
Nanomedicine Nanotechnology Biology and Medicine (2021) Vol. 37, pp. 102408-102408
Closed Access | Times Cited: 49
Metal-based compounds containing selenium: An appealing approach towards novel therapeutic drugs with anticancer and antimicrobial effects
Sandra Ramos-Inza, Daniel Plano, Carmen Sanmartín
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114834-114834
Open Access | Times Cited: 29
Modern Trends in Bio-Organometallic Ferrocene Chemistry
L. V. Snegur
Inorganics (2022) Vol. 10, Iss. 12, pp. 226-226
Open Access | Times Cited: 28
FETPY: a Diiron(I) Thio–Carbyne Complex with Prominent Anticancer Activity In Vitro and In Vivo
Ekatarina Mihajlović, Lorenzo Biancalana, Sanja Jelača, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 9, pp. 7553-7568
Open Access | Times Cited: 7
1,3,5-Triaza-7-phosphaadamantane and Cyclohexyl Groups Impart to Di-Iron(I) Complex Aqueous Solubility and Stability, and Prominent Anticancer Activity in Cellular and Animal Models
Michele De Franco, Lorenzo Biancalana, Chiara Zappelli, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 13, pp. 11138-11151
Closed Access | Times Cited: 7
Multifaceted chemical behaviour of metallocene (M = Fe, Os) quinone methides. Their contribution to biology
Anne Vessières, Yong Wang, Michael J. McGlinchey, et al.
Coordination Chemistry Reviews (2020) Vol. 430, pp. 213658-213658
Open Access | Times Cited: 48
Have molecular hybrids delivered effective anti-cancer treatments and what should future drug discovery focus on?
Shalini Shalini, Vipan Kumar
Expert Opinion on Drug Discovery (2020) Vol. 16, Iss. 4, pp. 335-363
Closed Access | Times Cited: 41
Recent Advances in Bioactive Flavonoid Hybrids Linked by 1,2,3-Triazole Ring Obtained by Click Chemistry
Daniela Pereira, Madalena Pinto, Marta Correia‐da‐Silva, et al.
Molecules (2021) Vol. 27, Iss. 1, pp. 230-230
Open Access | Times Cited: 39
Easily Available, Amphiphilic Diiron Cyclopentadienyl Complexes Exhibit in Vitro Anticancer Activity in 2D and 3D Human Cancer Cells through Redox Modulation Triggered by CO Release
Lorenzo Biancalana, Michele De Franco, Gianluca Ciancaleoni, et al.
Chemistry - A European Journal (2021) Vol. 27, Iss. 39, pp. 10169-10185
Open Access | Times Cited: 36
Promising heterometallic compounds as anticancer agents: Recent studies in vivo
Javier E. López‐Hernández, Marı́a Contel
Current Opinion in Chemical Biology (2022) Vol. 72, pp. 102250-102250
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top